4.7 Article

Association of medically assisted reproduction with offspring cord blood DNA methylation across cohorts

Journal

HUMAN REPRODUCTION
Volume 36, Issue 8, Pages 2403-2413

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/humrep/deab137

Keywords

assisted reproductive technology; medically assisted reproduction; IVF; DNA methylation; epigenetics; ALSPAC; MoBa; CHART

Funding

  1. US National Institute of Health [R01 DK10324]
  2. European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant [733206]
  3. NIHR Biomedical Centre at the University Hospitals Bristol NHS Foundation Trust
  4. University of Bristol
  5. UK Medical Research Council [102215/2/13/2]
  6. Wellcome [102215/2/13/2]
  7. UK BBSRC [BB/I025751/1, BB/I025263/1]
  8. UK Medical Research Council
  9. University of Bristol [MC_UU_00011/1, MC_UU_00011/5, MC_UU_00011/6]
  10. NHMRC (Australia) [1173314]
  11. Norwegian Ministry of Health and Care Services
  12. NIH/NIEHS [N01-ES-75558]
  13. NIH/NINDS [UO1 NS 047537-01, UO1 NS 047537-06A1]
  14. Intramural Research Program of the NIH, National Institute of Environmental Health Sciences [Z01-ES-49019]
  15. Norwegian Research Council/BIOBANK [221097]
  16. Research Council of Norway through its Centres of Excellence funding scheme [262700]
  17. Ministry of Education and Research
  18. National Health and Medical Research Council of Australia [1173314] Funding Source: NHMRC
  19. MRC [MC_PC_19009] Funding Source: UKRI

Ask authors/readers for more resources

This study did not find strong evidence linking medically assisted reproduction with variation in infant blood cell DNA methylation. While some associations were detected in two study cohorts, they were not replicated in another cohort, suggesting the need for further research to identify replicable variation in DNA methylation due to medically assisted reproduction.
STUDY QUESTION: Is cord blood DNA methylation associated with having been conceived by medically assisted reproduction? SUMMARY ANSWER: This study does not provide strong evidence of an association of conception by medically assisted reproduction with variation in infant blood cell DNA methylation. WHAT IS KNOWN ALREADY: Medically assisted reproduction consists of procedures used to help infertile/subfertile couples conceive, including ART. Due to its importance in gene regulation during early development programming, DNA methylation and its perturbations associated with medically assisted reproduction could reveal new insights into the biological effects of assisted reproductive technologies and potential adverse offspring outcomes. STUDY DESIGN, SIZE, DURATION: We investigated the association of DNA methylation and medically assisted reproduction using a case-control study design (N = 205 medically assisted reproduction cases and N = 2439 naturally conceived controls in discovery cohorts; N = 149 ART cases and N = 58 non-ART controls in replication cohort). PARTICIPANTS/MATERIALS, SETTINGS, METHODS: We assessed the association between medically assisted reproduction and DNA methylation at birth in cord blood (205 medically assisted conceptions and 2439 naturally conceived controls) at >450 000 CpG sites across the genome in two sub-samples of the UK Avon Longitudinal Study of Parents and Children (ALSPAC) and two sub-samples of the Norwegian Mother, Father and Child Cohort Study (MoBa) by meta-analysis. We explored replication of findings in the Australian Clinical review of the Health of adults conceived following Assisted Reproductive Technologies (CHART) study (N = 149 ART conceptions and N = 58 controls). MAIN RESULTS AND THE ROLE OF CHANCE: The ALSPAC and MoBa meta-analysis revealed evidence of association between conception by medically assisted reproduction and DNA methylation (false-discovery-rate-corrected P-value < 0.05) at five CpG sites which are annotated to two genes (percentage difference in methylation per CpG, cg24051276: Beta = 0.23 (95% CI 0.15,0.31); cg00012522: Beta = 0.47 (95% CI 0.31, 0.63); cg17855264: Beta = 0.31 (95% CI 0.20, 0.43); cg17132421: Beta = 0.30 (95% CI 0.18, 0.42); cg18529845: Beta = 0.41 (95% CI 0.25, 0.57)). Methylation at three of these sites has been previously linked to cancer, aging, HIV infection and neurological diseases. None of these associations replicated in the CHART cohort. There was evidence of a functional role of medically assisted reproduction-induced hypermethylation at CpG sites located within regulatory regions as shown by putative transcription factor binding and chromatin remodelling. LIMITATIONS, REASONS FOR CAUTIONS: While insufficient power is likely, heterogeneity in types of medically assisted reproduction procedures and between populations may also contribute. Larger studies might identify replicable variation in DNA methylation at birth due to medically assisted reproduction. WIDER IMPLICATIONS OF THE FINDINGS: Newborns conceived with medically assisted procedures present with divergent DNA methylation in cord blood white cells. If these associations are true and causal, they might have long-term consequences for offspring health.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available